Skip to main content

Table 1 Patient and tumour characteristics according to assigned huA33 dose level

From: Quantitative intratumoural microdistribution and kinetics of 131I-huA33 antibody in patients with colorectal carcinoma

Patient no. huA33 antibody dose level (mg/m2) Sex Age (years) Location of tumour resection or biopsy Reason for operation Tumour volume (cm3)a
1 0.25 M 63 Liver Bx 270
2 0.25 F 68 Lung M 37
3 0.25 M 56 Liver Bx 48
4 1 M 61 Liver Bx 132
5 1 F 52 Liver M 26
6 1 M 66 Liver M 2,099
7 5 M 62 Colon P 4
8 5 F 48 Liver Bx 1,770
9 5 F 60 Liver Bx 135
10 10 F 39 Liver M 80
11 10 M 59 Liver Bx 39
12 10 F 49 Liver Bx 131
  1. aTotal volume of tumour identified and measured on CT scan, or at pathology (Pt. 7). Bx, biopsy at time of intrahepatic artery port insertion; M, metastectomy; P, surgery for primary colon cancer.